Phytopharmaceuticals: The clinically documented herbal therapies which can bridge therapy gaps
PharmaBusiness
Phytopharmaceuticals … The clinically documented herbal therapies which can bridge therapy gaps
This category comprises of pharmaceutical formulations containing herbal extracts, distinguished by their clinically documented efficacy and safety profiles, substantiated by clinical studies.
The global market sales for phytopharmaceuticals stands at an impressive 62 billion USD, with Europe asserting its dominance, accounting for a commanding 45% share. Within Europe these products are available in both Rx and OTC categories and are marketed by both local phytopharma companies and big pharmaceutical companies.
Furthermore, European Parliament has extended its endorsement towards the integration of such medicinal products.
Two recent reports from the European Parliament have highlighted the advantages of integrative medicine, emphasizing the need for a comprehensive, integrative, and patient-centric approach
Hypertension and Diabetes are two major and expanding therapeutic domains, where therapy gaps exist. It is not uncommon to encounter patients afflicted by these conditions with unregulated blood pressure or glucose levels.
Phytopharmaceutical formulations can be integrated alongside allopathic medications, efficaciously regulating blood pressure and blood sugar levels or can be used as stand alone therapies
Phytopharmaceuticals formulations are available in various therapeutic domains with potential to bridge therapy gaps
Crucially, phytopharmaceuticals represent a distinct category formally recognized by regulatory authorities, with approval requisites aligning closely with those governing modern medicines. This dynamic presents abundance of avenues for pharmaceutical enterprises to introduce phytopharmaceuticals in domestic and international markets.
These are indeed intriguing times for pharmaceutical companies, poised to embark on the promising frontier of Phytopharmaceuticals.
August 8, 2024
New Product Planning
Genomic Research in Pharma Business: Unlocking the discovery of Personalized Medicines
August 8, 2024
Strategic Marketing
Pharma Business Marketing Tech Stack: Cutting-Edge Technologies empower pharmacos to optimize their Marketing and Sales Effectiveness
New Posts
Genomic Research in Pharma Business: Unlocking the discovery of Personalized Medicines
Pharma Business Marketing Tech Stack: Cutting-Edge Technologies empower pharmacos to optimize their Marketing and Sales Effectiveness
Herbal Medicines Efficacy and Safety hinges on the Quality of Herbal Extracts
Organisation Turnaround Mindset in Pharma Business: Strategies which deliver sustained high growth in Revenues and EBITDA
Phytopharmaceuticals: The clinically documented herbal therapies which can bridge therapy gaps